Abivax S.A. sell Snowman
Start price
28.06.21
/
50%
€30.50
Target price
28.06.22
€25.00
Performance (%)
-16.39%
End price
01.12.21
€25.50
Summary
This prediction ended on 01.12.21 with a price of €25.50. The price of Abivax S.A. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -16.39%. Snowman has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Abivax S.A. | - | - | - | - |
iShares Core DAX® | 0.936% | 1.535% | 21.949% | 19.324% |
iShares Nasdaq 100 | 3.064% | 1.968% | 29.275% | 38.772% |
iShares Nikkei 225® | 1.898% | -0.295% | 14.740% | 1.986% |
iShares S&P 500 | 1.653% | 2.318% | 27.064% | 40.403% |
According to Snowman what are the pros and cons of Abivax S.A. for the foreseeable future?
Pros
Future proof or reliable business model
Cons
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Little known brand
Below average Marketposition
Comments by Snowman for this prediction
In the thread Abivax S.A. diskutieren
Sell mit Kursziel 25,0
In the thread Trading Abivax S.A.
Sell beendet
Stopped prediction by Snowman for Abivax S.A.
Abivax S.A.
Start price
Target price
Perf. (%)
€25.50
01.12.21
01.12.21
€28.00
01.12.22
01.12.22
-31.92%
20.05.22
20.05.22
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected